Germany· DE-A57-97eacfd4e891bcad
Copaxone Pen
A medicinal product containing glatiramer acetate, registered in Germany by Teva Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Glatiramer Acetate
- Manufacturer
- Teva Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glatiramer acetate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCopaxoneTeva Neuroscience, Inc.
- SwedenCopaxone 20 mg/ml Injektionsvätska, lösning i förfylld spruta2care4 ApS
- CzechiaCOPAXONETeva Pharmaceuticals CR, s.r.o., Praha
- BelgiumCopaxone 20 mg/mlTeva
- FinlandCopaxoneTeva GmbH
- IrelandBrabio 20 mg/ml solution for injection, pre-filled syringeViatris Limited
- NorwayCopaxoneTeva GmbH
- CanadaCOPAXONETEVA CANADA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Copaxone, Perscleran
- Belgium · Copaxone, Glataxon
- Bulgaria · Копаксон, Ремурел
- Cyprus · Clift, Copaxone
- Czechia · Copaxone, Remurel
- Denmark · Copaxone, Copemyl
- Estonia · Copaxone, Remurel
- Spain · Copaxone, Glatiramero Viatris
- Finland · Copaxone, Glatimyl
- France · Copaxone, Copaxone Pen
- United Kingdom (Northern Ireland) · Brabio, Copaxone
- Greece · Clift, Copaxone
- Croatia · Copaxone, Remurel
- Hungary · Copaxone, Remurel
- Ireland · Brabio, Copaxone
- Iceland · Copaxone, Remurel
- Italy · Copaxone, Copemyl
- Lithuania · Copaxone, Remurel
- Luxembourg · Copaxone, Copaxone Pen
- Latvia · Copaxone, Remurel
- Malta · Galtipex
- Netherlands · Brabio, Copaxone
- Norway · Copaxone, Copemyl
- Poland · Copaxone, Remurel
- Portugal · Acetato De Glatirâmero Viatris, Clift
- Romania · Copaxone, Remurel
- Sweden · Copaxone, Glatimyl
- Slovenia · Copaxone, Remurel
- Slovakia · Copaxone, Copaxone Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7d4e030-b490-4b58-97c2-9096425f362a GET /v1/drugs/f7d4e030-b490-4b58-97c2-9096425f362a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use, Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Glatiramer Acetate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about glatiramer acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.